Ha habido 50 transacciones internas recientes registradas para Spruce Biosciences, Inc. (SPRB), incluyendo 20 compras y 27 ventas. El total de compras internas fue valorado en $677.67K y el total de ventas internas en $8.74M.
Internos destacados con actividad reciente incluyen Hooks Corwin Dale, Szwarcberg Javier B., Gharib Samir M.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — SPRB
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-09 |
Hooks Corwin Dale |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-03-09 |
Hooks Corwin Dale |
Chief Commercial Officer |
Concesión de RSU |
11,000 |
- |
- |
11,000 |
| 2025-12-31 |
Szwarcberg Javier B. |
Chief Executive Officer |
Concesión de RSU |
4,690 |
$4.53 |
$21.25K |
19,004 |
| 2025-12-15 |
Gharib Samir M. |
President and CFO |
Ejercicio de Opciones (Venta) |
496 |
- |
- |
497 |
| 2025-12-15 |
Szwarcberg Javier B. |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
1,480 |
- |
- |
1,480 |
| 2025-12-11 |
Ways Douglas Kirk |
Interim Chief Medical Officer |
Devolución de Acciones |
400 |
$169.50 |
$67.8K |
- |
| 2025-12-11 |
Gharib Samir M. |
President and CFO |
Ejercicio de Opciones (Venta) |
1,900 |
- |
- |
5,700 |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
Retención Fiscal de RSU |
2,194 |
$88.41 |
$193.97K |
12,998 |
| 2025-12-11 |
Spiegelman Daniel K |
Director |
Devolución de Acciones |
458 |
$564.00 |
$258.31K |
- |
| 2025-12-11 |
Grey Michael G |
Executive Chairman |
Devolución de Acciones |
387 |
$108.00 |
$41.8K |
- |
| 2025-12-11 |
Gharib Samir M. |
President and CFO |
Devolución de Acciones |
733 |
$1,506.00 |
$1.1M |
- |
| 2025-12-11 |
Simpson Camilla V |
Director |
Devolución de Acciones |
173 |
$108.00 |
$18.68K |
- |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
Devolución de Acciones |
10,000 |
$344.25 |
$3.44M |
- |
| 2025-12-11 |
Barretto-ko Percival |
Director |
Devolución de Acciones |
800 |
$169.50 |
$135.6K |
- |
| 2025-12-11 |
Walbert Keli |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-12-11 |
Walbert Keli |
Director |
Concesión de RSU |
3,400 |
$88.41 |
$300.59K |
3,400 |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
Concesión de RSU |
1,666 |
$104.13 |
$173.48K |
1,666 |
| 2025-12-10 |
Gharib Samir M. |
President and CFO |
Ejercicio de Opciones (Venta) |
514 |
- |
- |
1,539 |
| 2025-12-10 |
Szwarcberg Javier B. |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
1,196 |
- |
- |
3,588 |
| 2025-10-20 |
Gharib Samir M. |
President and CFO |
Ejercicio de Opciones (Venta) |
2,053 |
- |
- |
- |
| 2025-10-20 |
Szwarcberg Javier B. |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
4,784 |
- |
- |
- |
| 2025-10-06 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
Desconocido |
- |
- |
- |
1,051 |
| 2025-10-06 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
Venta Informativa |
25 |
$17.46 |
$436.39 |
1,050 |
| 2025-07-23 |
Ways Kirk |
Interim Chief Medical Officer |
Concesión de RSU |
30,000 |
$0.12 |
$3.71K |
30,000 |
| 2025-07-22 |
Spiegelman Daniel K |
Director |
Concesión de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Grey Michael G |
Executive Chairman |
Concesión de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Aynechi Tiba |
Director |
Concesión de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Muralidhar Bali |
Director |
Concesión de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Simpson Camilla V |
Director |
Concesión de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Barretto-ko Percival |
Director |
Concesión de RSU |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2024-12-16 |
Gharib Samir M. |
President and CFO |
Ejercicio de Opciones (Venta) |
37,250 |
- |
- |
74,500 |
| 2024-12-16 |
Szwarcberg Javier B. |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
111,000 |
- |
- |
222,000 |
| 2024-12-16 |
Charlton Ralph William Iii |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
31,750 |
- |
- |
63,500 |
| 2024-12-10 |
Gharib Samir M. |
President and CFO |
Ejercicio de Opciones (Venta) |
154,000 |
- |
- |
154,000 |
| 2024-12-10 |
Szwarcberg Javier B. |
Chief Executive Officer |
Retención Fiscal de RSU |
128,020 |
$0.54 |
$68.75K |
338,101 |
| 2024-12-10 |
Charlton Ralph William Iii |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
106,400 |
- |
- |
106,400 |
| 2024-05-22 |
Spiegelman Daniel K |
Director |
Concesión de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Grey Michael G |
Executive Chairman |
Concesión de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Aynechi Tiba |
Director |
Concesión de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Muralidhar Bali |
Director |
Concesión de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Simpson Camilla V |
Director |
Concesión de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Ways Kirk |
Director |
Concesión de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Barretto-ko Percival |
Director |
Concesión de RSU |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-03-21 |
Novo Holdings A/s |
10 Percent Owner |
Venta Informativa |
465,021 |
$0.75 |
$350.95K |
2,550,000 |
| 2024-03-20 |
Novo Holdings A/s |
10 Percent Owner |
Venta Informativa |
359,979 |
$0.73 |
$264.08K |
3,015,021 |
| 2024-03-19 |
Novo Holdings A/s |
10 Percent Owner |
Venta Informativa |
593,000 |
$0.76 |
$447.72K |
3,375,000 |
| 2024-03-18 |
Novo Holdings A/s |
10 Percent Owner |
Venta Informativa |
842,020 |
$0.77 |
$647.01K |
3,968,000 |
| 2024-03-14 |
Novo Holdings A/s |
10 Percent Owner |
Venta Informativa |
1,912,316 |
$0.89 |
$1.7M |
4,810,020 |
| 2024-03-14 |
Gharib Samir M. |
President and CFO |
Concesión de RSU |
154,000 |
- |
- |
154,000 |
| 2024-03-14 |
Szwarcberg Javier B. |
Chief Executive Officer |
Concesión de RSU |
358,800 |
- |
- |
358,800 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
